Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
BPC-157 demonstrates exceptional safety in animal toxicology studies, with comprehensive evaluations in mice, rats, rabbits, and dogs failing to establish a lethal dose (LD) across wide dose ranges extending from standard research doses (6 g/kg) to levels exceeding 1000-fold higher concentrations (20 mg/kg), with no evidence of acute toxicity, organ-specific damage, or systemic adverse effects even following repeated high-dose administration
It acts as an incretin and exerts a variety of physiological and pharmacological effects such as the promotion of insulin secretion [1]
Yes, these drugs have been approved for type 2 diabetes treatment and weight loss
ELAD was not powered for those outcomes, so it reads as encouraging but inconclusive
